PROVENTIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Proventil, and what generic alternatives are available?
Proventil is a drug marketed by Schering and Kindeva and is included in six NDAs.
The generic ingredient in PROVENTIL is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Proventil
A generic version of PROVENTIL was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROVENTIL?
- What are the global sales for PROVENTIL?
- What is Average Wholesale Price for PROVENTIL?
Summary for PROVENTIL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 133 |
| Clinical Trials: | 19 |
| Drug Prices: | Drug price information for PROVENTIL |
| Drug Sales Revenues: | Drug sales revenues for PROVENTIL |
| DailyMed Link: | PROVENTIL at DailyMed |
Recent Clinical Trials for PROVENTIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| AstraZeneca | Phase 2 |
| University Medical Center of Southern Nevada | N/A |
| Merck Sharp & Dohme Corp. | Phase 4 |
US Patents and Regulatory Information for PROVENTIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | PROVENTIL | albuterol | AEROSOL, METERED;INHALATION | 017559-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | PROVENTIL | albuterol sulfate | TABLET;ORAL | 017853-002 | May 7, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | PROVENTIL | albuterol sulfate | SYRUP;ORAL | 018062-001 | Jan 19, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROVENTIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Schering | PROVENTIL | albuterol sulfate | TABLET;ORAL | 017853-001 | May 7, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Schering | PROVENTIL | albuterol sulfate | TABLET;ORAL | 017853-001 | May 7, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Schering | PROVENTIL | albuterol | AEROSOL, METERED;INHALATION | 017559-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROVENTIL
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
